Call toll-free 800.328.1267
Something new happened in the stock market yesterday following a month of steady gains: some names are breaking out. Twenty three members of the S&P 500 made new 52-week highs on Monday. That was the most since April 21, according to TradeStation data. Six of...
Stocks advanced again last week as inflation-wary investors keep inching back into the market. The S&P 500 rose 0.36 percent between Friday, July 29, and Friday, August 5. It was the third straight weekly advance, returning the index to its highest level in two...
United Therapeutics spent more than a year consolidating around its 2015 highs. Now the biotech may be attempting a breakout. Notice the surge to new all-time highs late last month. The rally followed news that the Food & Drug Administration approved its Tyvaso...
Biotechnology stocks have pulled back dramatically, but positive news has been growing as the sector tries to stabilize at a historic level. Positive news has emerged on several companies in the industry, including takeovers, regulatory approvals and drug-trial data....
Stocks fell last week as the Federal Reserve got even more hawkish. However some potentially bullish trends are developing as money drains away from technology. The S&P 500 slid 1.3 percent between Friday, April 1, and Friday, April 8. It was the first negative...
The stock market hasn't just pulled back in 2022. It's also showing new trends as investors react to very different environment from recent years. This article will highlight the new conditions and what they could mean for your money. Here's the list: Traditional...
Pfizer has bounced in March after two negative months, and now it's having a quick pullback. The first pattern on today's chart is the 50-day moving average, which PFE recently crossed above. Other times the pharmaceutical giant moved over (or under) this MA were...
Stocks ended 2021 on a strong note as investors found opportunities in new sectors like health care and real estate. The S&P 500 rose 4.7 percent in December, rebounding from worries about the Federal Reserve and omicron variant of coronavirus. The index climbed...
Johnson & Johnson is often a dull stock, but it had some exciting price action yesterday. The health care giant dropped 1 percent in the initial seconds of trading, undercutting Friday's low. Buyers immediately came out of the woodwork, driving the stock to its...